111
Views
0
CrossRef citations to date
0
Altmetric
Priority Paper Evaluation

Mapping the Long Slow Progression of Neurodegeneration Leading to Alzheimer’s Disease

, &
Pages 567-571 | Published online: 14 Dec 2012

References

  • Bateman RJ , XiongC, BenzingerTLSet al. Clinical and biomarker changes in dominantly inherited Alzheimer‘s disease. N. Engl. J. Med. 367, 795–804(2012).
  • Jack CR Jr, Knopman DS, Jagust WJ et al. Hypothetical model of dynamic biomarkers of the Alzheimer‘s pathological cascade. Lancet Neurol.9, 119–128(2010).
  • Devanand DP , LiuX, TabertMHet al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer‘s disease. Biol. Psychiatry 64, 871–879(2008).
  • Gomar JJ , Bobes-BascaranMT, Conejero-GoldbergC, DaviesP, Goldberg TE; Alzheimer‘s Disease Neuroimaging Initiative. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in the Alzheimer‘s disease neuroimaging initiative. Arch. Gen. Psychiatry68, 961–969(2011).
  • Heister D , BrewerJB, MagdaS, BlennowK, McEvoy LK; Alzheimer‘s Disease Neuroimaging Initiative. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology77, 1619–1628(2011).
  • Landau SM , HarveyD, MadisonCMet al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75, 230–238(2010).
  • Bondi MW , SalmonDP, GalaskoD, ThomasRG, ThalLJ. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer‘s disease. Psychol. Aging14, 295–303(1999).
  • Tierney MC , YaoC, KissA, McDowellI. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology64, 1853–1859(2005).
  • Bäckman L , JonesS, BergerA, LaukkaE, SmallB. Cognitive impairment in preclinical Alzheimer‘s disease: a meta-analysis. Neuropsychology19(4), 520–531(2005).
  • Jedynak BM , LangA, LiuBet al. A computational neurodegenerative disease progression score: method and results with the Alzheimer‘s Disease Neuroimaging Initiative cohort. NeuroImage 63(3), 1478–1486(2012).
  • Salmon DP , ThomasRG, PayMMet al. Alzheimer‘s disease can be accurately diagnosed in very mildly impaired individuals. Neurology 59, 1022–1028(2002).
  • Chang YL , BondiMW, McEvoyLKet al. Global clinical dementia rating of 0.5 in MCI masks variability related to level of function. Neurology 76, 652–659(2011).
  • Klunk WE , PriceJC, MathisCAet al. Amyloid deposition begins in the striatum of Presenilin-1 mutation carriers from two unrelated pedigrees. J. Neurosci. 27, 6174–6184(2007).
  • Iadecola C . Neurovascular regulation in the normal brain and in Alzheimer‘s disease. Nat. Rev. Neurosci.5(5), 347–360(2004).
  • Zlokovic BV . Neurovascular pathways to neurodegeneration in Alzheimer‘s disease and other disorders. Nat. Rev. Neurosci.12(12), 723–738(2011).
  • Chen Y , WolkDA, ReddinJSet al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 77(22), 1977–1985(2011).
  • Alsop DC , DaiW, GrossmanM, DetreJA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer‘s disease. J. Alzheimers Dis.20(3), 871–880(2010).
  • Alsop DC , CasementM, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer‘s disease. Neuroimage42(4), 1267–1274(2008).
  • McKhann GM , KnopmanDS, ChertkowHet al. The diagnosis of dementia due to Alzheimer‘s disease: recommendations from the National Institute on Aging – Alzheimer‘s Association workgroup. Alzheimer‘s Dement. 7, 263–269(2011).
  • Albert MS , DeKoskyST, DicksonDet al. The diagnosis of mild cognitive impairment due to Alzheimer‘s disease: recommendations from the National Institute on Aging and Alzheimer‘s Association workgoup. Alzheimer‘s Dement. 7, 270–279(2011).
  • Sperling RA , AisenPS, BeckettLAet al. Toward defining the preclinical stages of Alzheimer‘s disease: recommendations from the National Institute on Aging – Alzheimer‘s Association workgroups on diagnostic guidelines for Alzheimer‘s disease. Alzheimer‘s Dement. 7, 280–292(2011).
  • McKhann G , DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM. Clinical diagnosis of Alzheimer‘s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer‘s disease. Neurology34, 939–944(1984).
  • Twamley E , RopackiS, BondiMW. Neuropsychological and neuroimaging changes in preclinical Alzheimer‘s disease. J. Int. Neuropsychol. Soc.12(5), 707–735(2006).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.